Changes in iron measures over menopause and associations with insulin resistance

Journal of Women's Health

Volumn 21, Issue 8, 2012, Pages 872-877

  Kim, Catherine ^a   Nan, Bin ^a   Kong, Shengchun ^a   Harlow, Siobhan ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SEX HORMONE BINDING GLOBULIN; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; CORRELATION ANALYSIS; ETHNIC DIFFERENCE; FEMALE; FERRITIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; IRON BLOOD LEVEL; IRON STORAGE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; STATISTICAL MODEL; TRANSFERRIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FERRITINS; HUMANS; INSULIN RESISTANCE; IRON; LONGITUDINAL STUDIES; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RECEPTORS, TRANSFERRIN; SEX HORMONE-BINDING GLOBULIN; TRANSFERRIN; WAIST CIRCUMFERENCE;

EID: 84864651852     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2012.3549     Document Type: Article

References (26)

1. Cho G, Shin J, Yi K, et al. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women. Menopause 2011;18:1120-1124.
2. Milman N, Byg K, Ovesen L, Kirchhoff M, Jurgensen K. Iron status in Danish women, 1984-1994: A cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload. Eur J Haematol 2003;71:51-61.
3. Looker A, Dallman P, Carroll M, Gunter E, Johnson C. Prevalence of iron deficiency in the United States. JAMA 1997;277:973-976.
4. Sowers M, Derby C, Jannausch M, Torrens J, Pasternak R. Insulin resistance, hemostatic factors, and hormone interac-tions in pre-and perimenopausal women: SWAN. J Clin Endocrinol Metab 2003;88:4904-4910.
5. Phelps G, Chapman I, Hall P, Braund W, Mackinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet 1989;2:233-234.
6. Punnonen K, Irjala K, Rajamaki A. Serum trasnferrin re-ceptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052.
7. Guyatt G, Oxman A, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron-deficiency anemia: An overview. J Gen Intern Med 1992;7:145-153.
8. Pradhan A, Manson J, Rifai N, Buring J, Ridker P. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
9. Ding E, Song Y, Manson J, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152-1163.
10. Sutton-Tyrrell K, Wildman R, Matthews K, et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic pre-menopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111:1242-1249.
11. Sowers M, McConnell D, Jannausch M, et al. Oestrogen metabolites in relation to isoprostanes as a measure of oxi-dative stress. Clin Endocrinol (Oxf) 2008;68:806-813.
12. Hanson R, Pratley R, Bogardus C, et al. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 2000;151:190-198.
13. Jiang R, Manson J, Meigs J, Ma J, Rifai N, Hu F. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004;291:711-717.
14. Sternfeld B, Wang H, Quesenberry C Jr, et al. Physical ac-tivity and changes in weight and waist circumference in midlife women: Findings from the Study of Women's Health Across the Nation. Am J Epidemiol 2004;160:912-922.
15. Torrens J, Sutton-Tyrrell K, Zhao X, et al. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: Study of Women's Health Across the Nation. Menopause 2009;16:257-264.
16. Liu J, Hankinson S, Stampfer M, Rifai N, Willett W, Ma J. Body iron stores and their determinants in healthy post-menopausal U.S. women. Am J Clin Nutr 2003;78:1160-1167.
17. Choi K, Lee K, Kim H, et al. Association among serum fer-ritin, alanine aminotransferase levels, and metabolic syn-drome in Korean postmenopausal women. Metabolism 2005;54:1510-1514.
18. Sun L, Franco O, Hu F, et al. Ferritin concentrations, meta-bolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 2008;93:4690-4696.
19. Vari I, Balkau B, Kettaneh A, et al. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007;30:1795-1801.
20. Forouhi N, Harding A, Allison M, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: Results from the EPIC-Norfolk prospective study. Diabetologia 2007;50:949-956.
21. Salonen J, Tuomainen T, Nyyssonnen K, Lakka H, Punno-nen K. Relation between iron stores and non-insulin-dependent diabetes in men: Case-control study. BMJ 1998; 317:727.
22. Lo J, Feigenbaum S, Yang J, Pressman A, Selby J, Go A. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1357-1363.
23. Luque-Ramirez M, Alvarez-Blasco F, Alpanes M, Escobar-Morreale H. Role of decreased circulating hepcidin concen-trations in the iron excess of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2011;96:846-852.
24. Chen X, Scholl T, Stein T. Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women. Diabetes Care 2006;29:1077-1082.
25. Huang X, Fung E, Yip C, Zeleniuch-Jacquotte A. Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy postmenopausal women. Blood Cell Mol Dis 2008;41:265-269.
26. Rajpathak S, Wylie-Rosett J, Gunter M, et al. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab 2009;11:472-479.